- Home
- SERV vs FENC Comparison
SERV vs FENC Comparison
Compare SERV & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERV | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | 35 |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.2M | 350.0M |
| IPO Year | 2023 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SERV | FENC |
|---|---|---|
| Price | $3.08 | $10.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $12.14 | ★ $17.67 |
| AVG Volume (30 Days) | ★ 2.3M | 115.7K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $207,545.00 | ★ $44,642,000.00 |
| Revenue This Year | $262.88 | $62.55 |
| Revenue Next Year | $248.20 | $42.10 |
| P/E Ratio | ★ N/A | $166.50 |
| Revenue Growth | ★ 92.49 | N/A |
| 52 Week Low | $3.17 | $5.65 |
| 52 Week High | $16.08 | $13.25 |
Technical Indicators
Market Signals| Indicator | SERV | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 21.87 | 44.62 |
| Support Level | N/A | $9.87 |
| Resistance Level | $4.80 | $10.66 |
| Average True Range (ATR) | 0.24 | 0.48 |
| MACD | -0.15 | -0.01 |
| Stochastic Oscillator | 0.80 | 38.89 |
Price Performance
Historical ComparisonAbout SERV Serve Robotics Inc.
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. The Segment derives revenue from (i) services via the Companies robot fleet, including delivery, branding and experiential services, (ii) access to software developed for the robot fleet, including certain autonomous capabilities, and (iii) access to data collected by the robot fleet, including navigation-related data. The majority of the revenue is derived from robot delivery services and food delivery platforms.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.